Ausgabe Sonderheft 1/2009
Inhalt (9 Artikel)
The biology of interleukin-2 efficacy in the treatment of patients with renal cell carcinoma
Antonio Romo de Vivar Chavez, Michael E. de Vera, Xiaoyan Liang, Michael T. Lotze
The application of high-dose interleukin-2 for metastatic renal cell carcinoma
David F. McDermott
Mechanism of action of everolimus in renal cell carcinoma
Bernard Escudier, John A. Thompson
Everolimus (RAD001) in the treatment of advanced renal cell carcinoma: biology and pathways
James M. G. Larkin, Rosemary E. J. Clarke, Lisa M. Pickering
Everolimus for renal cell carcinoma: predictive factors for response and future directions
Guru Sonpavde, Thomas E. Hutson